ICD115J ;ALB/DMR - YEARLY DRG UPDATE; October 01, 2020@15:42
 ;;18.0;DRG Grouper;**115**;October 20, 2000;Build 7
 ;Per VA Directive 6402, this routine should not be modified.
 ; Updates for DRGS 640-809
 Q
 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
 ;;640^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC^1.3152^3.6
 ;;641^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC^0.7814^2.6
 ;;642^10^MED^INBORN AND OTHER DISORDERS OF METABOLISM^1.3033^3.4
 ;;643^10^MED^ENDOCRINE DISORDERS WITH MCC^1.6451^5.1
 ;;644^10^MED^ENDOCRINE DISORDERS WITH CC^1.0617^3.6
 ;;645^10^MED^ENDOCRINE DISORDERS WITHOUT CC/MCC^0.7609^2.7
 ;;650^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITH MCC^4.4975^6.4
 ;;651^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITHOUT MCC^3.4584^5.4
 ;;652^11^SURG^KIDNEY TRANSPLANT^3.0044^4.4
 ;;653^11^SURG^MAJOR BLADDER PROCEDURES WITH MCC^5.4136^10.1
 ;;654^11^SURG^MAJOR BLADDER PROCEDURES WITH CC^2.7375^5.3
 ;;655^11^SURG^MAJOR BLADDER PROCEDURES WITHOUT CC/MCC^2.1078^3.3
 ;;656^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC^3.1376^5.2
 ;;657^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC^1.8442^2.8
 ;;658^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC^1.4804^1.7
 ;;659^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MCC^2.5889^5.9
 ;;660^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC^1.3459^2.9
 ;;661^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC^1.0484^1.8
 ;;662^11^SURG^MINOR BLADDER PROCEDURES WITH MCC^2.9967^7.1
 ;;663^11^SURG^MINOR BLADDER PROCEDURES WITH CC^1.459^3.5
 ;;664^11^SURG^MINOR BLADDER PROCEDURES WITHOUT CC/MCC^1.0616^1.8
 ;;665^11^SURG^PROSTATECTOMY WITH MCC^3.0891^7.9
 ;;666^11^SURG^PROSTATECTOMY WITH CC^1.7174^3.8
 ;;667^11^SURG^PROSTATECTOMY WITHOUT CC/MCC^1.0496^2
 ;;668^11^SURG^TRANSURETHRAL PROCEDURES WITH MCC^2.818^7.2
 ;;669^11^SURG^TRANSURETHRAL PROCEDURES WITH CC^1.5346^3.8
 ;;670^11^SURG^TRANSURETHRAL PROCEDURES WITHOUT CC/MCC^0.9626^2
 ;;671^11^SURG^URETHRAL PROCEDURES WITH CC/MCC^1.7119^3.9
 ;;672^11^SURG^URETHRAL PROCEDURES WITHOUT CC/MCC^0.9227^1.5
 ;;673^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC^3.698^8.8
 ;;674^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH CC^2.3822^6.1
 ;;675^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITHOUT CC/MCC^1.5865^2.7
 ;;682^11^MED^RENAL FAILURE WITH MCC^1.5008^4.4
 ;;683^11^MED^RENAL FAILURE WITH CC^0.9008^3.1
 ;;684^11^MED^RENAL FAILURE WITHOUT CC/MCC^0.6085^2.2
 ;;686^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC^1.8394^5.3
 ;;687^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH CC^1.0453^3.3
 ;;688^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC^0.7809^1.9
 ;;689^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITH MCC^1.1744^3.9
 ;;690^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC^0.8069^2.9
 ;;693^11^MED^URINARY STONES WITH MCC^1.4163^3.8
 ;;694^11^MED^URINARY STONES WITHOUT MCC^0.7827^2.1
 ;;695^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITH MCC^1.196^3.7
 ;;696^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITHOUT MCC^0.6921^2.3
 ;;697^11^MED^URETHRAL STRICTURE^1.1131^2.7
 ;;698^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC^1.6544^4.9
 ;;699^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH CC^1.0208^3.3
 ;;700^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITHOUT CC/MCC^0.7083^2.3
 ;;707^12^SURG^MAJOR MALE PELVIC PROCEDURES WITH CC/MCC^1.9619^2.2
 ;;708^12^SURG^MAJOR MALE PELVIC PROCEDURES WITHOUT CC/MCC^1.4585^1.4
 ;;709^12^SURG^PENIS PROCEDURES WITH CC/MCC^2.12^4.3
 ;;710^12^SURG^PENIS PROCEDURES WITHOUT CC/MCC^1.2343^1.7
 ;;711^12^SURG^TESTES PROCEDURES WITH CC/MCC^2.1229^5.1
 ;;712^12^SURG^TESTES PROCEDURES WITHOUT CC/MCC^1.1884^2.6
 ;;713^12^SURG^TRANSURETHRAL PROSTATECTOMY WITH CC/MCC^1.4507^2.6
 ;;714^12^SURG^TRANSURETHRAL PROSTATECTOMY WITHOUT CC/MCC^0.9585^1.5
 ;;715^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH CC/MCC^2.2075^5.4
 ;;716^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC^1.4222^1.5
 ;;717^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITH CC/MCC^1.8137^3.5
 ;;718^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITHOUT CC/MCC^1.1758^1.8
 ;;722^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC^1.8748^5.5
 ;;723^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC^1.1143^3.5
 ;;724^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.8095^2
 ;;725^12^MED^BENIGN PROSTATIC HYPERTROPHY WITH MCC^1.2409^4.1
 ;;726^12^MED^BENIGN PROSTATIC HYPERTROPHY WITHOUT MCC^0.7309^2.4
 ;;727^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITH MCC^1.621^4.9
 ;;728^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITHOUT MCC^0.8001^2.9
 ;;729^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITH CC/MCC^1.0039^3
 ;;730^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITHOUT CC/MCC^0.6216^1.9
 ;;734^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH CC/MCC^2.1736^3.4
 ;;735^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT CC/MCC^1.2602^1.6
 ;;736^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC^3.8872^7.9
 ;;737^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC^1.9738^3.9
 ;;738^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.3646^2.3
 ;;739^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC^3.6163^6.3
 ;;740^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC^1.787^2.7
 ;;741^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.2993^1.6
 ;;742^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC^1.7819^2.7
 ;;743^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC^1.162^1.6
 ;;744^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH CC/MCC^1.8824^4.6
 ;;745^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT CC/MCC^1.0359^1.9
 ;;746^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITH CC/MCC^1.6761^3.3
 ;;747^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT CC/MCC^0.8872^1.4
 ;;748^13^SURG^FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES^1.4049^1.4
 ;;749^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH CC/MCC^2.5172^5.5
 ;;750^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC^1.36^2
 ;;754^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.8525^5.1
 ;;755^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC^1.0847^3.3
 ;;756^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.9897^2.2
 ;;757^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.4916^5
 ;;758^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH CC^0.9926^3.7
 ;;759^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6462^2.6
 ;;760^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITH CC/MCC^0.9954^2.8
 ;;761^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITHOUT CC/MCC^0.6056^1.8
 ;;768^14^SURG^VAGINAL DELIVERY WITH O.R. PROCEDURES EXCEPT STERILIZATION AND/OR D&C^1.2181^3.2
 ;;769^14^SURG^POSTPARTUM AND POST ABORTION DIAGNOSES WITH O.R. PROCEDURES^1.5439^3.3
 ;;770^14^SURG^ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY^0.7987^1.7
 ;;776^14^MED^POSTPARTUM AND POST ABORTION DIAGNOSES WITHOUT O.R. PROCEDURES^0.7167^2.4
 ;;779^14^MED^ABORTION WITHOUT D&C^0.9892^1.8
 ;;783^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH MCC^1.7718^4.5
 ;;784^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH CC^1.0241^3.1
 ;;785^14^SURG^CESAREAN SECTION WITH STERILIZATION WITHOUT CC/MCC^0.8663^2.5
 ;;786^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH MCC^1.7495^4.3
 ;;787^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH CC^1.0511^3.3
 ;;788^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITHOUT CC/MCC^0.855^2.7
 ;;789^15^MED^NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY^1.8194^1.8
 ;;790^15^MED^EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, NEONATE^6.0001^17.9
 ;;791^15^MED^PREMATURITY WITH MAJOR PROBLEMS^4.0977^13.3
 ;;792^15^MED^PREMATURITY WITHOUT MAJOR PROBLEMS^2.4725^8.6
 ;;793^15^MED^FULL TERM NEONATE WITH MAJOR PROBLEMS^4.2093^4.7
 ;;794^15^MED^NEONATE WITH OTHER SIGNIFICANT PROBLEMS^1.4899^3.4
 ;;795^15^MED^NORMAL NEWBORN^0.2017^3.1
 ;;796^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH MCC^1.4184^2.5
 ;;797^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH CC^0.9959^2.4
 ;;798^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITHOUT CC/MCC^0.8112^2
 ;;799^16^SURG^SPLENIC PROCEDURES WITH MCC^4.9546^7.7
 ;;800^16^SURG^SPLENIC PROCEDURES WITH CC^2.8177^4.2
 ;;801^16^SURG^SPLENIC PROCEDURES WITHOUT CC/MCC^1.7897^2.3
 ;;802^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MCC^3.3903^7.7
 ;;803^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH CC^1.8582^3.8
 ;;804^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITHOUT CC/MCC^1.2104^1.7
 ;;805^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH MCC^1.0082^2.8
 ;;806^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH CC^0.7467^2.3
 ;;807^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITHOUT CC/MCC^0.6543^2
 ;;808^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC^2.1901^5.3
 ;;809^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC^1.2044^3.4
 ;;EXIT
